Experience with ceftaroline for treatment of methicillin-resistant Staphylococcus aureus pneumonia in a community hospital

Background: Methicillin-resistant Staphylococcus a ureus (MRSA) is an organism causing significant mortality and morbidity with nosocomial infections. Ceftaroline is a new cephalosporin antibiotic that has activity against MRSA. In the USA, this antibiotic has not been approved for use in pneumonia...

Descripción completa

Detalles Bibliográficos
Autores principales: Karki, Apurwa, Thurm, Craig, Cervellione, Kelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676793/
https://www.ncbi.nlm.nih.gov/pubmed/29147471
http://dx.doi.org/10.1080/20009666.2017.1374107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676793/
https://www.ncbi.nlm.nih.gov/pubmed/29147471
http://dx.doi.org/10.1080/20009666.2017.1374107

Ejemplares similares